Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the record history. Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:15.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the Record History; removed the funding-status notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:23:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and release version v3.4.1. Removed release version v3.4.0.
    Difference
    0.8%
    Check dated 2026-02-04T10:29:08.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - The Record History page now displays a Show glossary option and uses color-coded diffs (green for additions, red for deletions). It also shows a revision tag of v3.4.0, replacing the previous v3.3.4 tag.
    Difference
    1%
    Check dated 2026-01-28T06:28:32.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history shows an added Revision: v3.3.4 and a removal of Revision: v3.3.3 as part of the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:38:02.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the study record versions. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:41.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.